Qiagen NV | QIA - EPS Earnings Per Share


Qiagen NV reported $0.46 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.55 0.53 Nov/10
FY2026Q2 Jun/2026 0.52 0.60 Jul/23
FY2026Q1 Mar/2026 0.46 0.46 0.49 Apr/27
FY2025Q4 Dec/2025 0.50 0.52 0.59 Feb/04
FY2025Q3 Sep/2025 0.53 0.5 0.54 Nov/04




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
argenx SE USD 6.44 1.74 Jun/2026
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -0.85 0.58 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
IQVIA Holdings USD 2.9 0.52 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Organon & Co USD 0.71 0.08 Mar/2026
Qiagen NV USD 0.46 0.06 Mar/2026
Revvity USD 1.06 0.64 Mar/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026